Press Releases

Hepion Pharmaceuticals to Present at The Liver Meeting(R) 2019 November 7, 2019
Hepion Pharmaceuticals' CRV431 Reduces Liver Fibrosis in a Western Diet Model of NASH November 7, 2019
Hepion Pharmaceuticals to Present on CRV431 at the 3rd Annual NASH Summit October 23, 2019
Hepion Pharmaceuticals Announces Publication of Data Highlighting CRV431's Potential as a Treatment for Chronic Liver Diseases October 16, 2019
World-Renowned Liver Disease Expert, Dr. Stephen Harrison, Joins Hepion Pharmaceuticals as Consultant Medical Director October 10, 2019
Hepion Pharmaceuticals Strengthens Management Team with Three Key Promotions October 3, 2019
Hepion Pharmaceuticals to Present at the H. C. Wainwright 21st Annual Global Investment Conference September 4, 2019
Hepion Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements September 3, 2019
Hepion Pharmaceuticals Announces Dosing of First HBV Patient in 28-Day Study of CRV431 August 14, 2019
Hepion Pharmaceuticals Welcomes Dr. Stephen Harrison to its Scientific Advisory Board August 7, 2019

Get Important News and Updates by Email Subscribe